Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 297.00
Bid: 290.00
Ask: 304.00
Change: 2.00 (0.68%)
Spread: 14.00 (4.828%)
Open: 295.00
High: 297.00
Low: 290.00
Prev. Close: 295.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

8 May 2019 16:41

RNS Number : 4229Y
MaxCyte, Inc.
08 May 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMUWSVRKRAVRAR
Date   Source Headline
17th Aug 20237:00 amRNSTR-1: Notification of Major Holdings
10th Aug 20237:25 amRNSFiling of Form 10-Q
10th Aug 20237:00 amRNSSecond Quarter and Half-Year Results
8th Aug 20233:15 pmRNSTR-1: Notification of major holdings
7th Aug 20235:01 pmRNSTotal Voting Rights and Block Listing Return
1st Aug 20231:05 pmRNSStrategic Platform License with Prime Medicine
31st Jul 20235:26 pmRNSExercise of options and PDMR dealing
26th Jul 20232:31 pmRNSTR-1: Notification of major holdings
24th Jul 20235:08 pmRNSTR-1: Notification of major holdings
24th Jul 20235:06 pmRNSTR-1: Notification of major holdings
13th Jul 20231:05 pmRNSNotice of Second Quarter 2023 Financial Results
11th Jul 20237:00 amRNSTR-1: Notification of major holdings
10th Jul 20231:05 pmRNSSigning of Strategic Platform License
10th Jul 20237:00 amRNSTR-1: Notification of major holdings
7th Jul 20239:23 amRNSTotal Voting Rights
6th Jul 20234:41 pmRNSTR-1: Notification of major holdings
6th Jul 20231:05 pmRNSSigning of Strategic Platform License
29th Jun 20233:19 pmRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSExercise of options and PDMR dealing
23rd Jun 20233:46 pmRNSGrant of Options
23rd Jun 20237:17 amRNSResult of AGM
23rd Jun 20237:00 amRNSResult of AGM
21st Jun 202310:10 amRNSPublication of Annual Report
16th Jun 202312:32 pmRNSExercise of options and PDMR dealing
2nd Jun 20237:00 amRNSUpcoming Investor Conferences
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20237:22 amRNSFiling of Form 10-Q
11th May 20237:00 amRNSFirst Quarter Financial Results
9th May 20237:00 amRNSExercise of options and PDMR dealing
4th May 20231:05 pmRNSSigning of Strategic Platform License
3rd May 20234:22 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSNotice of First Quarter 2023 Financial Results
30th Mar 202312:46 pmRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of Chief Financial Officer
22nd Mar 20237:00 amRNSGrant of Options and PDMR Dealing
16th Mar 20237:01 amRNSFiling of Form 10-K
16th Mar 20237:00 amRNS2022 Full Year Results
8th Mar 20231:00 pmRNSEstablishment of New Scientific Advisory Board
7th Mar 20237:00 amRNSPreliminary Unaudited Q4 &FY 2022 Revenue Results
6th Feb 20233:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSNotice of Results
30th Jan 20237:00 amRNSExercise of options and PDMR dealing
4th Jan 20237:00 amRNSSigning of Strategic Platform License
5th Dec 20227:00 amRNSSigning of Strategic Platform License
2nd Dec 20225:22 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSNon-Executive Director Appointment
11th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20227:01 amRNSFiling of Form 10-Q
10th Nov 20227:00 amRNSMaxCyte Reports Third Quarter Financial Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.